Dr. Lerner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6560 Fannin St
Houston, TX 77030Phone+1 713-798-4001Fax+1 713-798-6005
Education & Training
Baylor College of MedicineResidency, Urology, 1986 - 1990
Virginia Mason Franciscan HealthResidency, Surgery, 1984 - 1986- Baylor College of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 1990 - Present
TX State Medical License 1985 - 2026
WA State Medical License 1985 - 1987- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Super Doctor SuperDoctors.com
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Genetic Susceptibility to Bladder Cancer Start of enrollment: 1998 Feb 10
Publications & Presentations
PubMed
- 4 citationsBladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Se...Roger Li, Patrick J Hensley, Shilpa Gupta, Hikmat Al-Ahmadie, Marko Babjuk
European Urology. 2024-12-01 - 2 citationsCorrelative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder C...Elizabeth R Plimack, Catherine Tangen, Melissa Plets, Rutika Kokate, Joanne Xiu
European Urology. 2024-10-01 - 1 citationsThree- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S...Mamta Parikh, Catherine Tangen, Maha H A Hussain, Shilpa Gupta, Sam Callis
European Urology Oncology. 2024-10-01
Press Mentions
Bladder Cancer Trial Finds Extended Lymph Node Surgery Doesn’t Improve SurvivalNovember 6th, 2024- Extended Lymphadenectomy Does Not Improve DFS or OS Among Patients with Localised Muscle Invasive Bladder CancerNovember 4th, 2024
- Extended Lymphadenectomy Fails to Improve Survival in Bladder CancerOctober 4th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
